• Zentalis Pharmaceuticals outlines its oncology focus as Nasdaq-listed biotech AD HOC NEWS Wed, 08 Jul 2026 20:35:49 GMT
• Zentalis Pharmaceuticals outlines oncology pipeline strategy as clinical programs advance AD HOC NEWS Tue, 07 Jul 2026 16:11:50 GMT
• ZNTL Stock Rallies To Near 22-Month Highs – An Analyst Sees Further 56% Upside After A Crucial Trial Update Stocktwits Mon, 29 Jun 2026 22:43:53 GMT
• Zentalis Pharmaceuticals Surges 14%: Biotech Stock Breaks Above Key Support Zone - Sector Sentiment dars.gov.et Mon, 29 Jun 2026 20:42:22 GMT
• Zentalis Pharmaceuticals, Inc.(NasdaqGM: ZNTL) added to Russell 2000 Index marketscreener.com Mon, 29 Jun 2026 18:53:14 GMT
• Zentalis Pharmaceuticals, Inc.(NasdaqGM:ZNTL) added to Russell Small Cap Comp Value Benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• zentalis pharmaceuticals, inc.(nasdaqgm: zntl) added to russell 3000e value benchmark marketscreener.com Sun, 28 Jun 2026 22:00:00 GMT
• zntl stock rallies to near 22-month highs – an analyst sees further 56% upside after a crucial trial update Stocktwits Sat, 27 Jun 2026 12:43:41 GMT
• zentalis pharmaceuticals, inc. actuals & estimates (nasdaq:zntl) TradingView Thu, 25 Jun 2026 17:40:25 GMT
• zntl stock rallies to near 22-month highs – an analyst sees further 56% upside after a crucial trial update Stocktwits Thu, 25 Jun 2026 02:54:13 GMT
• enterprise value to revenue forward of zentalis pharmaceuticals, inc. – nasdaq:zntl TradingView Wed, 24 Jun 2026 22:05:14 GMT
• Price to earnings forward of Zentalis Pharmaceuticals, Inc. – NASDAQ:ZNTL TradingView Wed, 24 Jun 2026 12:34:54 GMT
• zentalis pharmaceuticals inc (zntl) financial health: profitability & balance sheet analysis TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• Zentalis Pharmaceuticals (ZNTL) Edges Higher as Biotech Sector Sees Mixed Sentiment - Dividend Arbitrage dars.gov.et Sun, 21 Jun 2026 07:00:00 GMT
• zntl stock rallies to near 22-month highs – an analyst sees further 56% upside after a crucial trial update Stocktwits Fri, 19 Jun 2026 11:46:18 GMT
• zentalis (zntl) investors elect directors and ratify ernst & young at 2026 meeting Stock Titan Thu, 18 Jun 2026 20:03:41 GMT
• Zentalis Pharmaceuticals (ZNTL) director granted 57,100 restricted stock units Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• Zentalis Pharmaceuticals (ZNTL) director awarded 57,100 RSUs Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• Zentalis (ZNTL) director Enoch Kariuki granted 57,100 restricted stock units Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• rsu grant boosts zentalis (zntl) director jan skvarka's holdings Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• zentalis (zntl) director awarded 57,100 rsus, boosting holdings to 307,521 shares Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• zentalis pharmaceuticals inc (zntl) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 18:39:41 GMT
• Zentalis Pharmaceuticals Inc (ZNTL) Institutional Confidence TradingKey Wed, 17 Jun 2026 16:58:54 GMT
• zentalis pharmaceuticals inc (zntl) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 16:58:52 GMT
• zentalis pharmaceuticals inc (zntl) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 16:57:11 GMT
• zentalis pharmaceuticals inc (zntl) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 16:53:19 GMT
• Zentalis Pharmaceuticals Inc (ZNTL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Wed, 17 Jun 2026 05:23:16 GMT
• zentalis pharmaceuticals inc (zntl) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 05:21:20 GMT
• zentalis pharmaceuticals inc (zntl) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 04:52:59 GMT
• zentalis pharmaceuticals inc (zntl) institutional confidence TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• zentalis pharmaceuticals inc (zntl) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• zentalis pharmaceuticals inc (zntl) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• zentalis pharmaceuticals inc (zntl) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• Guggenheim Increases Zentalis Price Target, Sparking Investor Interest timothysykes.com Mon, 15 Jun 2026 07:00:00 GMT
• oppenheimer initiates zentalis pharmaceuticals(zntl.us) with buy rating, announces target price $9 Moomoo Mon, 15 Jun 2026 07:00:00 GMT
• zntl stock rallies to near 22-month highs – an analyst sees further 56% upside after a crucial trial update Stocktwits Sat, 13 Jun 2026 00:46:43 GMT
• number of shareholders of zentalis pharmaceuticals, inc. – nasdaq:zntl TradingView Thu, 11 Jun 2026 04:08:07 GMT
• Zentalis Pharmaceuticals Insider Sellers Vindicated After 10% Drop simplywall.st Tue, 09 Jun 2026 07:00:00 GMT
• zntl stock rallies to near 22-month highs – an analyst sees further 56% upside after a crucial trial update Stocktwits Mon, 08 Jun 2026 14:01:35 GMT
• zntl stock rallies to near 22-month highs – an analyst sees further 56% upside after a crucial trial update Stocktwits Fri, 05 Jun 2026 23:23:51 GMT
• zntl: azenosertib shows promise in proc, with strong efficacy and future combination plans underway TradingView Wed, 03 Jun 2026 20:42:39 GMT
• zentalis pharmaceuticals (zntl) jefferies global healthcare conference 2026 summary Quartr Wed, 03 Jun 2026 07:00:00 GMT
• press release: zentalis pharmaceuticals announces inducement grants under nasdaq listing rule 5635(c)(4) Moomoo Tue, 02 Jun 2026 07:00:00 GMT
• press release: zentalis pharmaceuticals announces inducement grants under nasdaq listing rule 5635(c)(4) Moomoo Mon, 01 Jun 2026 07:00:00 GMT
• zentalis pharmaceuticals announces inducement grants under nasdaq listing rule 5635(c)(4) Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• zentalis grants 191,000 stock options to new hires under nasdaq inducement rule. Pluang Mon, 01 Jun 2026 07:00:00 GMT
• cancer drug developer offers 191k stock options to two hires Stock Titan Mon, 01 Jun 2026 07:00:00 GMT
• Zentalis (ZNTL) director Shannon Campbell receives 114,200-share RSU award Stock Titan Wed, 27 May 2026 07:00:00 GMT
• Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of C... Yahoo Finance Wed, 27 May 2026 07:00:00 GMT
• Zentalis adds board member, commercial executive ahead of trial data Investing.com Wed, 27 May 2026 07:00:00 GMT
• zentalis (zntl) director campbell shannon files routine form 3 insider report Stock Titan Wed, 27 May 2026 07:00:00 GMT
• zentalis pharmaceuticals (zntl) expands board, awards rsus to new director Stock Titan Wed, 27 May 2026 07:00:00 GMT
• zentalis pharmaceuticals appoints shannon campbell to board and sarah kelly as svp of commercial strategy geneonline.com Wed, 27 May 2026 07:00:00 GMT
• zntl: azenosertib shows promising efficacy and safety in ovarian cancer, with pivotal data expected this year TradingView Tue, 26 May 2026 15:50:44 GMT
• zentalis pharmaceuticals inc at td cowen oncology innovation summit (virtual) transcript GuruFocus Tue, 26 May 2026 14:00:00 GMT
• h.c. wainwright maintains zentalis pharmaceuticals(zntl.us) with buy rating, maintains target price $10 Moomoo Tue, 26 May 2026 07:00:00 GMT
• h.c. wainwright reiterates zentalis stock rating on ovarian cancer data Investing.com Fri, 22 May 2026 07:00:00 GMT
• h.c. wainwright maintains zentalis pharmaceuticals(zntl.us) with buy rating, maintains target price $10 Moomoo Fri, 22 May 2026 07:00:00 GMT
• zntl stock price, quote & chart | zentalis pharmaceuticals inc (nasdaq:zntl) ChartMill Fri, 22 May 2026 07:00:00 GMT
• zentalis pharmaceuticals presents promising phase 1b muir trial results of azenosertib plus paclitaxel in platinum-resistant ovari... Minichart Fri, 22 May 2026 05:27:00 GMT
• zentalis to present ovarian cancer trial data at asco meeting by investing.com Investing.com Nigeria Fri, 22 May 2026 01:46:36 GMT
• zentalis pharmaceuticals (zntl) price target increased by 19.05% to 5.83 MSN Thu, 21 May 2026 19:04:07 GMT
• Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile o... GlobeNewswire Thu, 21 May 2026 07:00:00 GMT
• zentalis to present ovarian cancer trial data at asco meeting Investing.com Thu, 21 May 2026 07:00:00 GMT
• zentalis pharmaceuticals announces promising phase 1b results for azenosertib plus paclitaxel in ovarian cancer at asco 2026 Quiver Quantitative Thu, 21 May 2026 07:00:00 GMT
• phase 1b ovarian cancer data for zentalis (nasdaq: zntl) azenosertib combo Stock Titan Thu, 21 May 2026 07:00:00 GMT
• zntl sec filings - zentalis pharmaceuticals, inc. 10-k, 10-q, 8-k forms Stock Titan Thu, 21 May 2026 03:13:43 GMT
• zntl stock price, quote & chart | zentalis pharmaceuticals inc (nasdaq:zntl) ChartMill Mon, 18 May 2026 07:00:00 GMT
• zentalis pharmaceuticals stock (us98943l1070): q1 2026 results, clinical progress, and cash runway u AD HOC NEWS Sat, 16 May 2026 07:00:00 GMT
• a quick look at today's ratings for zentalis pharmaceuticals(zntl.us), with a forecast between $5 to $10 Moomoo Thu, 14 May 2026 21:28:35 GMT
• analysts are bullish on these healthcare stocks: actuate therapeutics, inc. (actu), agios pharma (agio) The Globe and Mail Thu, 14 May 2026 07:00:00 GMT
• oppenheimer maintains zentalis pharmaceuticals(zntl.us) with buy rating, maintains target price $9 Moomoo Wed, 13 May 2026 13:31:00 GMT
• zentalis pharmaceuticals stock (zntl): q1 2026 earnings and azenosertib milestone AD HOC NEWS Wed, 13 May 2026 12:48:30 GMT
• zentalis: buy rating reiterated as azenosertib strategy advances; $10 price target maintained on de-risked dosing and late-stage c... TipRanks Wed, 13 May 2026 11:54:37 GMT
• Zentalis Pharmaceuticals, Inc. Stock 12‑Month Price Target Raised to $6.5, Implies 52% Upside TradingView Wed, 13 May 2026 07:00:00 GMT
• Zentalis’s Azenosertib Strategy Hinges on DENALI Phase 2 Data The Clinical Trial Vanguard Wed, 13 May 2026 07:00:00 GMT
• zentalis pharmaceuticals to participate in upcoming investor conferences GlobeNewswire Wed, 13 May 2026 07:00:00 GMT
• zentalis pharmaceuticals reports first quarter 2026 financial results and clinical progress The Manila Times Wed, 13 May 2026 07:00:00 GMT
• is zentalis pharmaceuticals (zntl) attractive after q1 2026 earn GuruFocus Wed, 13 May 2026 04:41:15 GMT
• is zentalis pharmaceuticals (zntl) attractive after q1 2026 earn GuruFocus Tue, 12 May 2026 22:34:54 GMT
• zntl: azenosertib shows >30% orr in cyclin e1-positive proc, targeting a major unmet need TradingView Tue, 12 May 2026 21:14:55 GMT
• Zentalis Pharmaceuticals, Inc. 1Q 2026: Net income $(35.4)M, EPS $(0.50) — 10-Q Summary TradingView Tue, 12 May 2026 07:00:00 GMT
• zentalis pharmaceuticals reports first quarter 2026 financial results and clinical progress GlobeNewswire Tue, 12 May 2026 07:00:00 GMT
• zentalis (nasdaq: zntl) trims q1 2026 loss while pushing azenosertib toward pivotal ovarian cancer milestones Stock Titan Tue, 12 May 2026 07:00:00 GMT
• experimental ovarian cancer pill enters phase 3 chemo trial Stock Titan Tue, 12 May 2026 07:00:00 GMT
• zentalis pharmaceuticals inc reports results for the quarter ended march 31 - earnings summary TradingView Tue, 12 May 2026 07:00:00 GMT
• zentalis (zntl) trims q1 loss as azenosertib moves into phase 3 Stock Titan Tue, 12 May 2026 07:00:00 GMT
• press release: zentalis pharmaceuticals reports first quarter 2026 financial results and clinical progress Moomoo Tue, 12 May 2026 07:00:00 GMT
• zentalis pharmaceuticals inc expected to post a loss of 48 cents a share - earnings preview TradingView Fri, 08 May 2026 07:00:00 GMT
• zntl stock price, quote & chart | zentalis pharmaceuticals inc (nasdaq:zntl) ChartMill Fri, 08 May 2026 07:00:00 GMT
• this small-cap biotech stock just hit a near 22-month high – but this analyst still expects another 56% rally MSN Thu, 07 May 2026 14:00:22 GMT
• Zentalis Doses First Patient with Azenosertib in Phase III Trial | PharmExec Pharmaceutical Executive Wed, 06 May 2026 07:00:00 GMT
• Zentalis Launches ASPENOVA Phase 3 Trial of Azenosertib in Platinum-Resistant Ovarian Cancer The Clinical Trial Vanguard Wed, 06 May 2026 07:00:00 GMT
• bayer to acquire perfuse therapeutics for potential $2.45 billion geneonline.com Wed, 06 May 2026 07:00:00 GMT
• zntl sec filings - zentalis pharmaceuticals, inc. 10-k, 10-q, 8-k forms Stock Titan Wed, 06 May 2026 03:45:01 GMT
• zentalis doses first patient in phase 3 aspenova trial for cyclin e1-positive proc TradingView Tue, 05 May 2026 12:03:00 GMT
• Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positiv... GlobeNewswire Tue, 05 May 2026 07:00:00 GMT
• phase 3 ovarian cancer trial starts for zentalis (nasdaq: zntl) drug azenosertib Stock Titan Tue, 05 May 2026 07:00:00 GMT
• zentalis starts global phase 3 ovarian cancer trial against chemotherapy Stock Titan Tue, 05 May 2026 07:00:00 GMT
• zentalis begins phase 3 trial dosing for azenosertib in platinum-resistant ovarian cancer patients. Pluang Tue, 05 May 2026 07:00:00 GMT
• zentalis starts pivotal phase 3 aspenova ovarian cancer trial TipRanks Tue, 05 May 2026 07:00:00 GMT
• zentalis pharmaceuticals (zntl) price target increased by 19.05% to 5.83 MSN Mon, 04 May 2026 17:08:44 GMT
• zentalis pharmaceuticals announces inducement grant under nasdaq listing rule 5635(4) marketscreener.com Mon, 04 May 2026 13:12:19 GMT
• this small-cap biotech stock just hit a near 22-month high – but this analyst still expects another 56% rally MSN Mon, 04 May 2026 06:58:52 GMT
• zentalis pharmaceuticals announces inducement grant under nasdaq listing rule 5635(c)(4) The Manila Times Sat, 02 May 2026 07:00:00 GMT
• zentalis pharmaceuticals (zntl) price target increased by 19.05% to 5.83 MSN Fri, 01 May 2026 16:04:27 GMT
• Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Yahoo Finance Fri, 01 May 2026 07:00:00 GMT
• New Zentalis hire gets 26,000 stock options at $4.09 a share Stock Titan Fri, 01 May 2026 07:00:00 GMT
• zentalis (zntl) schedules 2026 virtual meeting on directors, auditor and executive pay Stock Titan Thu, 30 Apr 2026 20:06:27 GMT
• [def 14a] zentalis pharmaceuticals, inc. definitive proxy statement Stock Titan Thu, 30 Apr 2026 20:06:27 GMT
• zntl technical analysis | trend, signals & chart patterns | zentalis pharmaceuticals inc (nasdaq:zntl) ChartMill Thu, 30 Apr 2026 07:00:00 GMT
• zentalis pharmaceuticals (zntl) price target increased by 19.05% to 5.83 MSN Wed, 29 Apr 2026 21:12:39 GMT
• zentalis pharmaceuticals (zntl) price target decreased by 14.14% to 5.42 MSN Wed, 29 Apr 2026 13:12:01 GMT
• this small-cap biotech stock just hit a near 22-month high – but this analyst still expects another 56% rally MSN Tue, 28 Apr 2026 18:44:21 GMT
• this small-cap biotech stock just hit a near 22-month high – but this analyst still expects another 56% rally MSN Mon, 27 Apr 2026 20:32:33 GMT
• zentalis pharmaceuticals (zntl) price target increased by 19.05% to 5.83 MSN Sat, 25 Apr 2026 03:13:48 GMT
• Zentalis Pharmaceuticals Announces Abstract Acceptance at ASCO 2026 Featuring Azenosertib in Combination with Paclitaxel for Plati... Yahoo Finance Tue, 21 Apr 2026 07:00:00 GMT
• ovarian cancer drug combo data lands june asco presentation Stock Titan Tue, 21 Apr 2026 07:00:00 GMT
• Zentalis (ZNTL) Locks In Its Cancer Drug Dose; Jefferies Raises the Target Yahoo Finance Mon, 20 Apr 2026 07:00:00 GMT
• zntl: zentalis presents promising data on azenosertib at aacr 20 GuruFocus Sat, 18 Apr 2026 03:00:00 GMT
• zentalis presents preclinical data on cancer drug azenosertib by investing.com Investing.com India Sat, 18 Apr 2026 02:11:46 GMT
• zentalis to present azenosertib preclinical data in tnbc at aacr meeting TipRanks Fri, 17 Apr 2026 19:42:05 GMT
• Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet... GlobeNewswire Fri, 17 Apr 2026 07:00:00 GMT
• In resistant breast cancer mice, Zentalis drug drove 7 of 8 complete responses Stock Titan Fri, 17 Apr 2026 07:00:00 GMT
• zentalis presents preclinical data on cancer drug azenosertib Investing.com Fri, 17 Apr 2026 07:00:00 GMT
• zntl: zentalis presents promising data on azenosertib at aacr 20 GuruFocus Fri, 17 Apr 2026 07:00:00 GMT
• zentalis pharmaceuticals presents promising preclinical data on azenosertib in triple-negative breast cancer and insights on cycli... Quiver Quantitative Fri, 17 Apr 2026 07:00:00 GMT
• zentalis (nasdaq: zntl) unveils azenosertib tnbc and cyclin e1 ovarian cancer data at aacr 2026 Stock Titan Fri, 17 Apr 2026 07:00:00 GMT
Zentalis Pharmaceuticals, Inc(NASDAQ:ZNTL) 
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidates are the ZN-c5, an oral selective estrogen receptor degrader that is in a Phase 1/2 clinical ...
Website: http://www.zentalis.com
Full Time Employees: 110
CEO: Anthony Y. Sun
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends